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Host immune responses and peritumoral stromal reactions in different basal cell
carcinoma subtypes: histopathological comparison of basosquamous carcinoma and
high-risk and low-risk basal cell carcinoma subtypes
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Background/aim: The literature does not include sufficient data on the associations between host immune responses and stromal
reactions in different basal cell carcinoma (BCC) subtypes. The aim of the study was to compare host immune responses and stromal
reactions between basosquamous carcinoma (BSC) and high-risk (HR) and low-risk (LR) BCC subtypes.
Materials and methods: The study included 35 BSC, 40 HR-BCC, and 40 LR-BCC patients. Age, sex, lesion location, density of
peritumoral/adjacent perivascular inflammation, presence of lymphoid follicle formation, and stromal reaction type were compared
between groups.
Results: In all 3 groups, age, sex distribution, and lesion location were similar. Overall, 70% of lesions in the LR-BCC group exhibited
mild peritumoral inflammation, whereas in the BSC and HR-BCC groups dense inflammation was observed in 50% and 57.5% of
lesions, respectively (P < 0.001). All lesions (100%) in the LR-BCC group had fibromyxoid stroma, whereas 61.8% and 80% of lesions in
the BSC and HR-BCC groups, respectively, had desmoplastic stroma (P < 0.001).
Conclusion: The BSC and HR-BCC groups were similar in terms of host immune responses and stromal reactions. Furthermore, BSC
and HR-BCC were associated with dense peritumoral inflammation, adjacent perivascular inflammation, and desmoplastic stroma.
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1.Introduction
Basosquamous carcinoma (BSC) is a rare variant of basal
cell carcinoma (BCC) characterized by neoplastic cells,
with both squamoid and basaloid differentiation. BSC is
generally regarded as having an aggressive course and a
high risk of recurrence and metastasis (1–3). Although it
is widely known that BSC also has desmoplastic stroma,
research on stromal and peritumoral inflammatory
reactions in BSC is lacking (1). Furthermore, associations
between host immune responses and stromal reactions in
different BCC subtypes are not clearly known. As such,
the aim of the present study was to evaluate peritumoral
inflammation and stromal reaction patterns in BSC and
compare them with those in low-risk (LR) and high-risk
(HR) BCC subtypes.
2. Materials and methods
This retrospective study examined the clinical and
histological features of 115 lesions in 115 patients
* Correspondence: nilybayram@hotmail.com
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diagnosed between January 2011 and February 2014.
Lesions were obtained by searching the pathology
department’s computerized database using the terms
‘diagnosed as BCC’ and ‘diagnosed as BSC’. All lesions
identified via this search were then reexamined
microscopically and conventional stainings (Alcian blue
and Masson’s trichrome) were performed on new 4-µmthick cut sections. Patients with insufficient clinical data
and/or histopathological specimens were excluded from
the study. The clinical and histopathological data for 35
BSC, 40 LR-BCC, and 40 HR-BCC patients were included
in the study. The regional ethics committee approved the
study protocol.
The following clinical parameters obtained from
pathological reports were evaluated: age, sex, and lesion
location. Lesion location was grouped as follows: head and
neck region (subgrouped as scalp, forehead, periorbital
region, cheek, ear, nose, and neck), trunk, or extremity.
BCC subtype, host immune responses, and peritumoral

DUMAN et al. / Turk J Med Sci
stromal reactions were evaluated as histopathological
parameters. For evaluation of histopathological parameters
formalin-fixed, paraffin-embedded hematoxylin and eosin
(H&E)-stained sections were reexamined, and Alcian blue
and Masson’s trichrome stainings were performed on new
cut sections to evaluate stromal reaction types. Lesions
were histopathologically diagnosed as BSC if areas of both
BCC and squamous cell carcinoma (SCC) were admixed
together in a single tumor, with a transition zone between
them. Collision tumors, keratotic BCC, and basaloid SCC
were excluded. Collision tumors were defined as distinct
BCC and SCC components with distinct and independent
origin in the epidermis without a transition zone between
them (1). Keratotic BCC was defined as BCC exhibiting
central keratinization in some nodules, with uniform basal
and squamoid components, without a transition zone or
densely collagenized proplastic stroma (1,4). Furthermore,
basaloid SCC was defined as a high grade variant of SCC
composed of highly atypical basaloid cells, with abrupt foci
of squamous differentiation in nests without a transition
zone and frequently associated with comedo-type necrosis
and epidermal squamous atypia or SCC in situ (5,6).
Subtypes of BCC were defined as previously described
(7,8):
1. Nodular BCC: A tumor with rounded masses of
peripherally palisading atypical basaloid cells with
well-circumscribed outer margins in the dermis.
2. Micronodular subtype: A poorly circumscribed tumor
composed of infiltrative small rounded nodules and
nests that are ≤0.15 mm in diameter.
3. Superficial BCC: A tumor with nests of peripherally
palisading basaloid cells protruding from and
connected to the undersurface of the epidermis.
4. Infiltrative BCC: A poorly circumscribed tumor
composed of infiltrative elongated strands and cords of
basaloid cells.
Patients with superficial and nodular BCC constituted
the LR-BCC group, and those with micronodular
and infiltrative BCC constituted the HR-BCC group.
If ≥2 subtypes were observed in the same lesion, the
predominant subtype was accepted as the subtype.
As components of host immune response, the density
of peritumoral inflammation, the presence of lymphoid
follicle formation, and the density of perivascular
inflammation in the adjacent dermis were evaluated. The
density of peritumoral inflammation was scored according
to Kaur et al. as follows (7):
• 0: No inflammation.
• 1: Mild inflammation, scattered clusters of
inflammatory infiltrate surrounding <25% of the
tumor nests.
• 2: Moderate inflammation, inflammatory infiltrate
surrounding 25%–75% of the nests.

•

3: Dense inflammation, thick clusters or sheets of
inflammatory infiltrate surrounding >75% of the nests.
Furthermore, the density of perivascular inflammation
in the adjacent dermis was graded as follows:
0: No or occasional, inflammatory cells.
Mild: Few loosely arranged inflammatory cells.
Moderate: <3 concentric rows of inflammatory cells.
Dense: ≥3 concentric rows of inflammatory cells.
Peritumoral stromal reactions were evaluated based on
cellularity (hypo/hypercellular), type of collagen bundles
(thin/thick), and myxoid change according to Kaur et
al. and were categorized as fibromyxoid or desmoplastic
stroma (7).
Statistical analysis was performed using SPSS 18.0
for Windows (SPSS Inc., Chicago, IL, USA). Continuous
variables are presented as mean ± SD or median (range),
and categorical variables are presented as percentage. The
normality of the distribution of numeric variables was
evaluated using the Kolmogorov–Smirnov test. One-way
analysis of variance was used to compare continuous
variables between the BSC, LR-BCC, and HR-BCC groups.
The chi-square test was used to identify associations
between categorical variables. The level of statistical
significance was set at P < 0.05.
3. Results
The study included 115 lesions in 115 patients (40 LR-BCC
cases, 40 HR-BCC cases, and 35 BSC cases). The mean age
of the patients in the LR-BCC, HR-BCC, and BSC groups
was 65 ± 11.4 years, 69.4 ± 11.1 years, and 70.3 ± 11.1 years,
respectively, and the female/male ratio in each group was
17:23, 25:15, and 17:18, respectively. Age and sex did not
differ significantly between the 3 groups (P = 0.184). In
all 3 groups the vast majority of the lesions were located
in the head and neck region (HR-BCC group: 97.5%;
BSC group: 94.3%; LR-BCC group: 92.5%). Although
the difference was not significant, in the LR-BCC group
cheek localization predominated (32.5%), whereas nasal
localization predominated in the HR-BCC group (37.5 %)
and BSC group (28.6%) (P = 0.090).
In the LR-BCC group, 4 (10%) of the lesions were
superficial BCC and the remaining 36 (90%) were nodular
BCC. In the HR-BCC group, 10 (25%) of the lesions were
micronodular BCC and the remaining 30 were infiltrative
BCC. In all 115 lesions examined (except for 1 nodular
BCC lesion) peritumoral inflammation was observed. The
density of inflammation in the 80 BCC lesions was mild
in 30 (37.5%) (28 LR-BCC, 2 HR-BCC) lesions, moderate
in 24 (30%) (9 LR-BCC, 15 HR-BCC) lesions, and dense
in 25 (31%) (2 LR-BCC, 23 HR-BCC) lesions. Among the
BCC lesions, 76% of the lesions with dense inflammation
were infiltrative BCC, whereas 83.3% of the lesions with
mild inflammation were nodular BCC. In the BSC group,
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mild, moderate, and dense inflammation was observed
in 4 (11.4%), 13 (37.1%), and 18 (51.4%) of the lesions,
respectively. In the LR-BCC group, 28 (70%) lesions
exhibited mild inflammation, whereas 18 (51.4%) and 23
(57.5%) of the lesions in the BSC and HR-BCC groups,
respectively, exhibited dense inflammation (P < 0.001)
(Figures 1–5).
Among the 115 lesions included in the study, lymphoid
follicle formation was observed in only 8 (7%) lesions (7 in
the HR-BCC group [5 infiltrative BCC and 2 micronodular
BCC] and 1 in the LR-BCC group [nodular BCC]) (P =
0.003).

In all, 53 (46.1%) of the 115 lesions had desmoplastic
stroma, versus fibromyxoid stroma in 62 (53.9%) of the
lesions (Figures 6 and 7). In lesions with desmoplastic
stroma, hypercellular stroma with thick collagen bundles
was detected by Masson’s trichrome stain, whereas in
lesions with fibromyxoid stroma, hypocellular myxoid
stroma was detected by Alcian blue stain (Figures 8 and
9). Desmoplastic stroma was most commonly observed
in lesions with dense (56.6%) and moderate (39.6%)
inflammation, whereas fibromyxoid stroma was most
commonly observed in lesions with mild inflammation
(51.6%).

Figure 1. Nodular BCC with mild inflammation (H&E, 200×).

Figure 2. Superficial BCC with mild inflammation (H&E, 200×).

Figure 3. Micronodular BCC with moderate inflammation
(H&E, 400×).

Figure 4. Infiltrative BCC with dense inflammation (H&E, 200×).
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Figure 5. BSC with a transition zone with dense inflammation
(H&E, 400×).

Figure 6. Tumor cells separated by myxoid stroma (H&E, 400×).

Figure 7. Tumor cells separated by desmoplastic stroma (H&E,
400×).

Figure 8. Histological section showing myxoid stroma reaction
with Alcian blue (400×).

All lesions (100%) in the LR-BCC group had
fibromyxoid stroma, whereas 21 (61.8%) and 32 (80%)
of the lesions in the BSC group and HR-BCC group,
respectively, had desmoplastic stroma (P < 0.001). In
the HR-BCC group all of the infiltrative BCC cases had
desmoplastic stroma, whereas 80% of the micronodular
BCC cases had fibromyxoid stroma. Perivascular
inflammation in adjacent dermis was present in 91.4%,
97.5%, and 55% of the lesions in the BSC, HR-BCC,

and LR-BCC groups, respectively (P < 0.001). All of the
lesions with dense perivascular inflammation (100%) were
observed in the HR-BCC (65%) and BSC (35%) groups.
Statistical analysis showed that there was no association
between lesion location and sex, age, or peritumoral
inflammation (P = 0.375, P = 0.146, and P = 0.697,
respectively), or between stromal reactions and sex, age,
or peritumoral inflammation (P = 0.064, P = 0.351, and
P = 0.351, respectively). A detailed comparison of the
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Figure 9. Histological section showing desmoplastic stroma
reaction with Masson’s trichrome (200×).

BSC, LR-BCC, and HR-BCC groups is shown in Table
1. A comparison of host immune responses and stromal
reactions according to BCC subtype is shown in Table 2.

4. Discussion
The correlation between host immune responses and BCC
subtypes is a contentious issue. Kaur et al. reported that
significant stromal and inflammatory patterns correlate
with BCC subtypes and tumor progression (7). They
observed moderately dense peritumoral inflammation in
superficial BCC with features of old regression, whereas
little or no peritumoral inflammation was observed in
micronodular BCC. Furthermore, they did not observe
dense inflammation in any infiltrative BCC. Lesions
with dense inflammation were more commonly noted
in the LR-BCC (superficial/nodular) group than in the
HR-BCC (infiltrative/micronodular/morphoeic) group
in their study. In contrast, in the present study most of
the infiltrative BCC lesions had dense inflammation and
most of the micronodular BCC lesions had moderately
dense inflammation. Furthermore, lesions with dense
inflammation were most commonly observed in the
present study’s HR-BCC group. In addition, unlike Kaur
et al. (7), we did not evaluate regression components in
BCC lesions and, furthermore, the number of superficial
BCC cases in the present study was limited, which makes it
difficult to compare the superficial BCC findings. In Kaur
et al.’s study, lymphoid follicle formation was infrequent
(3%) and was associated with HR-BCC (7). Similarly, in the
present study lymphoid follicle formation was observed in

Table 1. Comparison of the BSC, LR-BCC, and HR-BCC groups.
Clinicopathological feature

BSC
(n = 35)

HR-BCC
(n = 40)

LR-BCC
(n = 40)

P

Mean age, years, mean ± SD

70.3 ± 11.1

69.4 ± 11.1

65 ± 11.4

0.098

Female/male

17/18

25/15

17/23

0.184

Location, n (%)
• Head-neck
• Trunk
• Extremity

33 (94.3)
0 (0)
2 (5.7)

39 (97.5)
1 (2.5)
0 (0)

37 (92.5)
1 (2.5)
0 (0)

Peritumoral inflammation, n (%)
• Absent
• Mild
• Moderate
• Dense

0 (0)
4 (11.4)
13 (37.1)
18 (51.4)

0 (0)
2 (5)
15 (37.5)
23 (57.5)

1 (2.5)
28 (70)
9 (22.5)
2 (5)

Adjacent perivascular inflammation, n (%)
• Absent
• Mild
• Moderate
• Dense

3 (8.6)
12 (34.3)
13 (37.1)
7 (20)

1 (2.5
6 (15)
20 (50)
13 (32.5)

18 (45)
16 (40)
6 (15)
0 (0)

Lymphoid follicle formation

0 (0)

1 (2.5)

8 (7)

0.003

Peritumoral stroma
• Fibromyxoid
• Desmoplastic

14 (40)
21 (60)

8 (20)
32 (80)

40 (100)
0 (0)

<0.001
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Table 2. Comparison of host immune responses and stromal reactions between the LR-BCC and HR-BCC groups.
LR-BCC (n = 40)
Feature

HR-BCC (n = 40)
P

Superficial BCC
(n = 4)

Nodular BCC
(n = 36)

Micronodular
BCC (n = 10)

Infiltrative BCC
(n = 30)

Peritumoral inflammation, n (%)
• Absent
• Mild
• Moderate
• Dense

0 (0)
3 (75)
0 (0)
1 (25 %)

1 (2.8)
25 (69.4)
9 (25)
1 (2.8)

0 (0)
1 (10)
5 (50)
4 (40)

0 (0)
1 (3.3)
10 (33.3)
19 (63.3)

Adjacent perivascular inflammation, n (%)
• Absent
• Mild
• Moderate
• Dense

1 (25)
2 (50)
1(25)
0 (0)

17 (47.2)
14 (38.9)
5 (13.9)
0 (0)

1 (10)
3 (30)
4 (40)
2 (20)

0 (0)
3 (10)
16 (53.3)
11 (36.7)

Lymphoid follicle formation, n (%)

0 (0)

1 (2.8)

2 (20)

5 (16.7)

0.131

Peritumoral stroma, n (%)
• Fibromyxoid
• Desmoplastic

4 (100)
0 (0)

36 (100)
0 (0)

8 (80)
2 (20)

0 (0)
30 (100)

<0.001

only 7% of lesions and was also associated with HR-BCC.
Moreover, in Kaur et al.’s study (7), sex- and site-specific
differences were not observed, as in the present study. In
contrast to Kaur et al.’s study (7), we also scored the density
of perivascular inflammation in the adjacent dermis and
noted that dense perivascular inflammation was associated
with HR-BCC and BSC.
The functional role of peritumoral inflammation in
BCC is not clear. In previous studies both antitumor
and protumor effects of peritumoral inflammation were
reported (9). Differences in findings between studies
might be related to the different types of immune cells in
peritumoral inflammation, i.e. an increase in the number
of regulatory T cells suppresses antitumor response and is
associated with a poor prognosis, whereas dendritic cells
and tumor-associated macrophages play a role in tumor
eradication (10–12).
The presence of denser inflammation in the HR-BCC
and BSC groups in the present study might have been
due to two factors: inflammatory cells could be recruited
in response to some characteristics of the tumors, or
inflammatory cells could secrete factors that influence
the BCC phenotype. Delineation of the inflammatory
cell types in peritumoral inflammation in such tumors is
needed to further understand their functional roles.
The association between BCC subtypes and
peritumoral stroma is also contentious. Lesack and
Naugler evaluated the morphometric characteristics of
tumor nests and their associated peritumoral stroma in
98 digitized BCC histology slides (including superficial,
nodular, and infiltrative lesions), and they reported that

<0.001

<0.001

the infiltrative subtype was associated with thicker stroma
and a lower tumor/stroma ratio (13). Dixon et al. and
Jacobs et al. observed that fibrous stroma was associated
with less aggressive tumors, and that the incidence of
hyalinization in stroma increased with BCC aggressiveness
(14,15). Bartos et al. reported that there was marked
dermal fibroplasia and chronic inflammatory infiltration
of varying intensity in the majority of relapsing BCC
lesions (16). Similarly, Pieh et al. showed that multiple
recurrences were associated with sclerosing BCC (17).
Kaur et al. also evaluated stromal reactions in various BCC
subtypes and noted that infiltrative/morphoeic BCC was
associated with desmoplastic tumor stroma (7). Similarly,
in the present study all infiltrative BCC lesions had
desmoplastic stroma. However, Kaur et al. reported loss of
stromal tumor responses in micronodular BCC, whereas
most micronodular BCC lesions in the present study had
fibromyxoid stroma (7). Despite some differences between
these studies, all the findings indicate that there are both
quantitative and qualitative differences in peritumoral
stroma in different BCC subtypes. However the functional
role of peritumoral stroma in BCC remains unclear
(13,18,19).
Peritumoral stroma is composed largely of activated
fibroblasts and inflammatory cells in a complex interaction
with tumor nests. Many paracrine factors, including
extracellular matrix proteins and growth factors, are
secreted by both stromal fibroblasts and inflammatory
cells in stroma, and these are able to change the expression
of many genes and affect tumor growth, angiogenesis, and
metastasis (13,20). To date, identification of the precise
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mechanisms underlying the complex interactions between
stroma and tumor requires additional research.
The present findings show that desmoplastic stroma
was associated with dense inflammation, which might
have been due to two factors: inflammatory cells secreting
factors that change stromal characteristics, or stromaderived factors that may recruit additional inflammatory
cells. A better understanding of the interactions between
peritumoral inflammation and stromal characteristics
would be possible if the types and functions of immune
cells in peritumoral inflammation were identified.
In contrast to earlier studies, the present study also
evaluated host immune responses and stromal reactions in
BSC. Although the literature is lacking in studies on stromal
reactions in BSC, they are suggested to be desmoplastic by

some authors (1). In addition, the present findings show
that although some BSC lesions had fibromyxoid stroma,
most of the BSC lesions had desmoplastic stroma and
dense inflammation, as in the HR-BCC group. The present
findings also add support for considering BSC in the HRBCC group.
In conclusion, BSC lesions in the present study were
similar to HR-BCC lesions in terms of host immune
responses and stromal reactions. Furthermore, dense
peritumoral inflammation and desmoplastic stroma were
associated with HR-BCC and BSC. In order to gain a better
understanding of the functional role of host peritumoral
inflammation and stroma in BCC subtypes, additional
research is required.
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